Search filters

List of works by Michael Grundman

11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study

scientific article published on 26 February 2010

A phase 1 clinical trial of the sigma-2 receptor complex allosteric antagonist CT1812, a novel therapeutic candidate for Alzheimer's disease

scholarly article by Michael Grundman et al published 2019 in Alzheimer's & dementia (New York, N. Y.)

A roadmap for the prevention of dementia II: Leon Thal Symposium 2008.

scientific article published on March 2009

A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium

scientific article published on May 2008

Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup

scientific article

Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis

scientific article

Brain MRI hippocampal volume and prediction of clinical status in a mild cognitive impairment trial

scientific article published in August 2002

Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force

scientific article published in July 2013

Developing a national strategy to prevent dementia: Leon Thal Symposium 2009.

scientific article

Hippocampal volume is associated with memory but not monmemory cognitive performance in patients with mild cognitive impairment.

scientific article published in January 2003

Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment

scientific article published in June 2005

The clinical promise of biomarkers of synapse damage or loss in Alzheimer's disease

scientific article published on 02 March 2020

Paulina is supported by:

About Paulina

Help